Showing results (1491-1500 of 1,529) with videos related to

Sort By:
Pageof 153
Cancer Research|October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transferJ W Simons, B Mikhak, J F Chang, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignanciesW G Nelson, J W Simons, B Mikhak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2020
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevoT Karn, C Denkert, K E Weber, et al.
Nature Communications|October 6, 2025
Extremely poleward shift of Antarctic Circumpolar Current by eccentricity during the Last InterglacialLijuan Lu, Xufeng Zheng, Michael E Weber, et al.
Nature Communications|January 29, 2025
Precession modulates the poleward expansion of atmospheric circulation to the Arctic OceanYi Zhong, Zhengyao Lu, Stefanie Kaboth-Bahr, et al.
Scientific Reports|January 6, 2017
Antarctic ice sheet discharge driven by atmosphere-ocean feedbacks at the Last Glacial TerminationC J Fogwill, C S M Turney, N R Golledge, et al.
BMC Cancer|March 9, 2018
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer historyChristoph Engel, Kerstin Rhiem, Eric Hahnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2018
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto StudyPeter A Fasching, Sibylle Loibl, Chunling Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.
The Lancet. Oncology|December 14, 2017
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapyCarsten Denkert, Gunter von Minckwitz, Silvia Darb-Esfahani, et al.
Pageof 153